Max Wolff

Clinical Researcher, MIND Foundation / OVID Clinic Berlin

Speaking at ALPS Conference 2026

The Case for Considering Psychedelics as Tools, Not Treatments

Directs the MIND Foundation's Augmented Psychotherapy Training program and practices as a psychotherapist at OVID Clinic Berlin — one of the two sites in Germany's compassionate-use psilocybin program. Involved in the EPIsoDE psilocybin trial run jointly by Mannheim's Central Institute of Mental Health and Charité Berlin. His most-cited paper, "Learning to Let Go," appeared in Frontiers in Psychiatry (2020).

Profile

Related on Altitude

Encyclopedia: Psilocybin
Our coverage: Germany's compassionate-use psilocybin program

← Back to Conference Speakers